2014
DOI: 10.1186/2251-6581-13-60
|View full text |Cite
|
Sign up to set email alerts
|

Mitochondrial dysfunction in obesity: potential benefit and mechanism of Co-enzyme Q10 supplementation in metabolic syndrome

Abstract: Co-enzyme Q10 (Co-Q10) is an essential component of the mitochondrial electron transport chain. Most cells are sensitive to co-enzyme Q10 (Co-Q10) deficiency. This deficiency has been implicated in several clinical disorders such as heart failure, hypertension, Parkinson’s disease and obesity. The lipid lowering drug statin inhibits conversion of HMG-CoA to mevalonate and lowers plasma Co-Q10 concentrations. However, supplementation with Co-Q10 improves the pathophysiological condition of statin therapy. Recen… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
56
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 69 publications
(56 citation statements)
references
References 143 publications
(177 reference statements)
0
56
0
Order By: Relevance
“…For instance, vitamin Co-Q10 supplementation is used during the treatment of obesity, oxidative stress (T2DM) and the inflammatory process in MetS. Co-Q10 served as an antioxidant by acting as a cofactor and activator of mitochondrial uncoupling proteins, responsible for the reduction in ROS production, endothelial dysfunction and hypertension [105,106]. Similarly, numerous other vitamins with antioxidant properties have also been developed to treat MetS induced by oxidative stress and mitochondrial dysfunctions.…”
Section: Biomolecules Mediated Therapy For Altered Mitochondrial Dynamentioning
confidence: 99%
“…For instance, vitamin Co-Q10 supplementation is used during the treatment of obesity, oxidative stress (T2DM) and the inflammatory process in MetS. Co-Q10 served as an antioxidant by acting as a cofactor and activator of mitochondrial uncoupling proteins, responsible for the reduction in ROS production, endothelial dysfunction and hypertension [105,106]. Similarly, numerous other vitamins with antioxidant properties have also been developed to treat MetS induced by oxidative stress and mitochondrial dysfunctions.…”
Section: Biomolecules Mediated Therapy For Altered Mitochondrial Dynamentioning
confidence: 99%
“…Coenzyme Q10 (CoQ10) or ubiquinone, a lipid-soluble [13] and vitamin-like compound [14], acts as a crucial cofactor in the mitochondrial respiratory chain as well as a natural scavenger of free radicals [15]. It is synthesized by cells of the body and also found in abundance in the human diet [16].…”
Section: Introductionmentioning
confidence: 99%
“…The primary function of CoQ10 in cells is in generating energy; being at the core of cellular energy processes CoQ10 has potential for reduce weight by improving (Alam and Rahman, 2014) ; Inhibition of CoQ10 synthesis strongly triggered adipocyte differentiation while increment of CoQ10 acts in inverse direction (Bour et al, 2011). CoQ10 treatment increases fat oxidation and energy consumption in adipose tissue.…”
Section: Discussionmentioning
confidence: 99%